Parkinson's Disease (PD) is a progressive neurological disorder that affects millions of people worldwide, characterized by tremors, stiffness, and difficulty with balance and coordination. This disorder results from the degeneration of dopamine-producing neurons in the brain, leading to a range of symptoms that can severely impact daily life. While medications exist to manage these symptoms, they often come with side effects and may lose efficacy over time.
As researchers continue to seek effective treatments for PD, cannabis has emerged as a promising option for managing symptoms and improving the quality of life. Cannabis contains cannabinoids that interact with the body's endocannabinoid system, a network of chemical signals and cellular receptors that regulate various physiological processes, including mood, pain sensation, and movement. Two primary cannabinoids, THC (tetrahydrocannabinol) and CBD (cannabidiol), have been studied for their potential therapeutic effects on PD.
According to an October 2024 review article, “ CBD's potential impact on Parkinson's disease: An updated overview ,” preclinical studies show CBD's potential to relieve both motor and non-motor symptoms. For motor symptoms, CBD may offer neuroprotective effects, potentially slowing disease progression. For non-motor symptoms, CBD's anxiolytic and antidepressant properties could provide significant relief, enhancing overall quality of life.
The 2024 article noted, however, that definitive conclus.
